-
EP3381474
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3381474
| EP3381474 - HISTONE DEACETYLASE INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCS) AND USE IN THERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.08.2019 Database last updated on 19.10.2024 | |
| Former | The application has been published Status updated on 31.08.2018 | Most recent event Tooltip | 02.08.2019 | Application deemed to be withdrawn | published on 04.09.2019 [2019/36] | Applicant(s) | For all designated states Alfasigma S.p.A. Via Ragazzi del '99, 5 40133 Bologna / IT | [N/P] |
| Former [2018/40] | For all designated states Alfasigma S.p.A. Via Ragazzi del '99 n. 5 40133 Bologna / IT | Inventor(s) | 01 /
VESCI, Loredana Via Piero Gherardi 20 00125 Roma / IT | 02 /
DE SANTIS, Rita Via Anchise 103 00040 Pomezia (RM) / IT | 03 /
MILAZZO, Ferdinando Maria Via Chiusi 11 00139 Roma / IT | 04 /
GIANNINI, Giuseppe Via Boezio 46/B 00071 Pomezia (RM) / IT | 05 /
TADDEI, Maurizio Via Uopini 58 , Monteriggioni 53035 Monteriggioni, Siena / IT | 06 /
FALTONI, Valentina Via Salvo D'Acquisto 10° 52048 Monte San Savino (AR) / IT | 07 /
PETRICCI, Elena Strada del Petriccio e Belriguardo 82 53100 Siena / IT | [2018/40] | Representative(s) | Hiebl, Inge Elisabeth Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [2018/40] | Application number, filing date | 17163065.0 | 27.03.2017 | [2018/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3381474 | Date: | 03.10.2018 | Language: | EN | [2018/40] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.09.2017 | Classification | IPC: | A61K47/68, A61P35/00, A61P31/18 | [2018/40] | CPC: |
A61K47/6803 (EP,EA,KR,US);
A61K31/4015 (KR);
A61K47/6849 (KR,US);
A61K47/6851 (EP,KR);
A61K47/6889 (KR,US);
A61K9/0078 (EP,KR,US);
A61P31/18 (EP,KR);
A61P35/00 (EP,KR,US);
A61P35/02 (KR);
A61P35/04 (US);
C07K16/2863 (US);
C07K16/32 (US);
A61K2039/505 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/40] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | ANTIKÖRPERWIRKSTOFFKONJUGATE AUF BASIS VON HISTONDEACETYLASEINHIBITOREN UND VERWENDUNG IN DER THERAPIE | [2018/40] | English: | HISTONE DEACETYLASE INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCS) AND USE IN THERAPY | [2018/40] | French: | CONJUGUÉS ANTICORPS-MÉDICAMENT (CAM) À BASE D'INHIBITEURS DE L'HISTONE DÉSACÉTYLASE ET LEUR UTILISATION EN THÉRAPIE | [2018/40] | Examination procedure | 04.04.2019 | Application deemed to be withdrawn, date of legal effect [2019/36] | 17.04.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2019/36] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.03.2019 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2015157595 (MEDIMMUNE LLC [US]); |